Unknown

Dataset Information

0

A progenitor cell origin of myeloid malignancies.


ABSTRACT: All cancers rely on cells that have properties of long-term self-renewal or "stemness" to maintain and propagate the tumor, but the cell of origin of most cancers is still unknown. Here, we design a stochastic mathematical model of hematopoietic stem and progenitor cells to study the evolutionary dynamics of cancer initiation. We consider different evolutionary pathways leading to cancer-initiating cells in JAK2V617F-positive myeloproliferative neoplasms (MPN): (i) the JAK2V617F mutation may arise in a stem cell; (ii) a progenitor cell may first acquire a mutation conferring self-renewal, followed by acquisition of the JAK2V617F mutation; (iii) the JAK2V617F mutation may first emerge in a progenitor cell, followed by a mutation conferring self-renewal; and (iv) a mutation conferring self-renewal to progenitors may arise in the stem cell population without causing a change in the stem cell's phenotype, followed by the JAK2V617F mutation emerging in a progenitor cell. We find mathematical evidence that a progenitor is the most likely cell of origin of JAK2V617F-mutant MPN. These results may also have relevance to other tumor types arising in tissues that are organized as a differentiation hierarchy.

SUBMITTER: Haeno H 

PROVIDER: S-EPMC2757818 | biostudies-other | 2009 Sep

REPOSITORIES: biostudies-other

altmetric image

Publications

A progenitor cell origin of myeloid malignancies.

Haeno Hiroshi H   Levine Ross L RL   Gilliland D Gary DG   Michor Franziska F  

Proceedings of the National Academy of Sciences of the United States of America 20090921 39


All cancers rely on cells that have properties of long-term self-renewal or "stemness" to maintain and propagate the tumor, but the cell of origin of most cancers is still unknown. Here, we design a stochastic mathematical model of hematopoietic stem and progenitor cells to study the evolutionary dynamics of cancer initiation. We consider different evolutionary pathways leading to cancer-initiating cells in JAK2V617F-positive myeloproliferative neoplasms (MPN): (i) the JAK2V617F mutation may ari  ...[more]

Similar Datasets

| S-EPMC4716890 | biostudies-literature
| S-EPMC5314811 | biostudies-other
| S-EPMC7677169 | biostudies-literature
| S-EPMC6851577 | biostudies-literature
| S-EPMC4131762 | biostudies-literature
| S-EPMC8698609 | biostudies-literature
| S-EPMC3729750 | biostudies-literature
| S-EPMC5292675 | biostudies-literature
| S-EPMC4972405 | biostudies-literature